Aster Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.7K Buy
1,051
+964
+1,108% +$80.2K 0.03% 476
2026
Q2
$5.86K Sell
87
-1,208
-93% -$80.5K ﹤0.01% 712
2026
Q1
$88.4K Buy
1,295
+344
+36% +$24K 0.03% 353
2025
Q4
$63.1K Buy
+951
New +$61.5K 0.03% 426
2025
Q3
– Sell
-135
Closed -$11.8K – 1063
2025
Q2
$11.8K Buy
+135
New +$10.6K ﹤0.01% 771
2025
Q1
– Sell
-8,990
Closed -$699K – 1352
2024
Q4
$699K Buy
+8,990
New +$666K 0.27% 98

Other funds holding DXCM

Aster Capital Management's DXCM Position: Q3 2026 in Review

Aster Capital Management increased its DexCom (DXCM) stake by 1,108% in Q3 2026, buying an estimated $80.2K and bringing the position to 1,051 shares worth $90.7K. The position accounts for 0.03% of the portfolio, ranked #476.

Aster Capital Management first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $699K in Q4 2024. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Aster Capital Management held 1,051 shares of DexCom worth $90.7K as of Q3 2026.
  • Aster Capital Management bought 964 DexCom shares in Q3 2026, an estimated $80.2K.
  • DexCom made up 0.03% of Aster Capital Management's portfolio in Q3 2026, its #476 holding.
  • Aster Capital Management first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • Aster Capital Management's DexCom position peaked at $699K in Q4 2024.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.